• No results found

Supplementary appendix

N/A
N/A
Protected

Academic year: 2021

Share "Supplementary appendix"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

(1)

Supplementary appendix

This appendix formed part of the original submission and has been peer reviewed.

We post it as supplied by the authors.

Supplement to: Efficace F, Gaidano G, Breccia M, et al. Prognostic value of self-reported

fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre,

prospective, observational, cohort study. Lancet Oncol 2015; published online Sept 22.

http://dx.doi.org/10.1016/S1470-2045(15)00206-5.

(2)

1

APPENDIX ONLINE

Supplementary Table 1. Distribution of hemoglobin levels by patients’ self-reported baseline fatigue.

Self-reported levels of fatigue (EORTC QLQ-C30) Hemoglobin (g/dl) – Mean (SD)

0 9.79 (1.68) 11 10.31 (2.24) 22 10.05 (1.69) 33 9.27 (1.70) 44 9.18 (2.58) 55 8.99 (1.47) 66 9.04 (2.01) 77 9.24 (1.43) 88 8.87 (2.10) 100 8.31 (1.12)

Abbreviations: EORTC QLQ-C30, European Organization for Research and

Treatment of Cancer, Quality of Life Questionnaire-Core 30,SD, standard

deviation.

Legend : the table shows the distribution of mean hemoglobin levels according to the observed scores of patients’ self-reported fatigue scale of EORTC QLQ-C30 questionnaire. Fatigue scores of the EORTC QLQ-C30 range between 0 and 100, with higher scores indicating higher level of fatigue.

(3)

2

APPENDIX ONLINE

General list of participating centers and Investigators involved:

Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont. Novara, Italy (Gianluca Gaidano, Monia Lunghi, Clara De Ambrogi)

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy (Giuliana Alimena, Massimo Breccia, Maria Pia Loglisci)

Department of Hematology, University of Rome “Cattolica S. Cuore”. Rome, Italy (Maria Teresa Voso, Marianna Criscuolo)

Department of Medical Sciences, University of Cagliari. Cagliari, Italy (Giorgio La Nasa, Giovanni Caocci) Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University. Innsbruck, Austria (Reinhard Stauder, Britta Halter)

Ematologia e Centro Trapianti. Ospedale Oncologico di Riferimento Regionale “Armando Businco”. Cagliari, Italy (Emanuele Angelucci, Anna Angela Di Tucci)

Department of Haematology, AZ St Jan Brugge-Oostende, Belgium (Dominik Selleslag, Tina Ducheyne) Department of Hematology and Stem Cell Transplantation Unit, IRCCS “Casa Sollievo della Sofferenza” Hospital. San Giovanni Rotondo, Italy (Nicola Cascavilla, Grazia Sanpaolo)

Department of Medicine I, University hospital Dresden “Carl Gustav Carus”. Dresden, Germany (Uwe Platzbecker, Susann Pinkert, Susann Knack)

Department of Medicine, Department of Haematology, General University Hospital, Charles University, Prague, Czech Republic (Anna Jonasova)

Department of Internal Medicine, CHU Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole, 1 avenue I. Joliot-Curie, 31059 Toulouse Cedex 9, France (Odile Beyne-Rauzy, Nicolas Ferrieres)

Hematology, Department of Biomedicine and Prevention, Tor Vergata University. Rome, Italy (Sergio Amadori, Francesco Buccisano)

Department of Emergency and Organ Transplantation, Hematology Section, University of Bari. Bari, Italy (Giorgina Specchia, Alessandra Ricco)

UO Ematologia, AOU “Policlinico-V.Emanuele”. Catania, Italy (Giuseppe Palumbo, Elena Schinocca, Marco Ragusa)

St James’s Institute of Oncology, Bexley Wing. Leeds, UK (David Bowen, Ayna Beden)

Leukemia Department. The University of Texas MD Anderson Cancer Center. Texas, Houston, USA (Khanh Nguyen, Guillermo Garcia-Manero, Christina Meyers)

Department of Haematology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Shenyang, China (Huiyong Zhang)

School of Humanities and Management, Guangdong Medical College. Dongguan, China (Chonghua Wan, Yang Zheng)

(4)

3 Department of Haematology, S. Giovanni-Addolorata Hospital. Rome, Italy (Luciana Annino, Susanna Fenu)

Department of Internal Medicine I, University of Freiburg Medical Centre. Freiburg, Germany (Michael Lübbert, Johannes Waldschmidt)

Department of Oncology-Hematology, Hospital Center “Pugliese-Ciaccio”. Catanzaro, Italy (Luciano Levato, Stefano Molica, Maria Lentini)

Department of Internal Medicine, University of Pavia-IRCCS Policlinico San Matteo Foundation. Pavia, Italy (Carlo Balduini, Rosangela Invernizzi)

Complex Operative Hematology and Transplantation Unit, Lecce Local Health Service, Lecce, Italy (Nicola Di Renzo, Claudia Quintavalle)

Department of Public Health, College of Public Health, National Taiwan University, Roosevelt Road. Taipei, Taiwan, Republic of China (Weichu Chie)

Department of Haematology, Bradford Institute of Health Research. Bradford, UK (Sam Ackroyd, Victoria Drew)

Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute. Milan, Italy (Fabio Ciceri)

Oncology Department, CHC–Clinique Saint-Joseph. Liège, Belgium (Christian Focan)

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York. New York, USA (Stephen Nimer, Virginia Klimek, Emily Dolezal)

Department of Haematology, AZ Middelheim. Antwerp, Belgium (Robrecht De Bock, Jan Christiaens) Department of Haematology, Hospital de Jolimont. La Louviere, Belgium (Christophe Ravoet, Petre Helene) Istituto Oncologico Romagnolo per la Cura dei Tumori. Meldola, Italy (Maria Benedetta Giannini, Francesca Fabbri)

Haematology Unit, Sapienza University, Polo Pontino. Latina, Italy (Sergio Mecarocci)

Department of Haematology, University Campus Bio-medico, Roma, Italy (Giuseppe Avvisati, Carolina Nobile)

Division of Hematology, Niguarda Ca' Granda Hospital. Milano, Italy (Enrica Morra)

Division of Hematology, Università di Torino, Ospedale San Giovanni Battista. Torino, Italy (Giorgia Matta) Department of Onco-hematology, S. Maria della Misericordia Hospital. Rovigo, Italy (Rossella Paolini)

(5)

4

List of participating centers and Principal Investigators by patients included:

PARTICIPATING CENTRE PRINCIPAL

INVESTIGATOR

RECRUITED PATIENTS PER CENTRE

Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont. Novara, Italy

Gianluca Gaidano 40

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy

Giuliana Alimena 29

Department of Hematology, University of Rome “Cattolica S.

Cuore”. Rome, Italy Maria Teresa Voso 26

Department of Medical Sciences, University of Cagliari. Cagliari, Italy

Giorgio La Nasa 24

Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University.

Innsbruck, Austria

Reinhard Stauder 16

Ematologia e Centro Trapianti. Ospedale Oncologico di Riferimento Regionale “Armando Businco”.

Cagliari, Italy

Emanuele Angelucci 15

Department of Haematology, AZ St Jan Brugge-Oostende, Belgium

Dominik Selleslag 13

Department of Hematology and Stem Cell Transplantation Unit, IRCCS “Casa Sollievo della Sofferenza” Hospital. San Giovanni Rotondo, Italy

Nicola Cascavilla 11

Department of Medicine I, University hospital Dresden “Carl

Gustav Carus”. Dresden, Germany Uwe Platzbecker 10

Department of Medicine, Department of Haematology, General University Hospital, Charles University, Prague,

Czech Republic

Anna Jonasova 8

Department of Internal Medicine, CHU Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole, 1 avenue I. Joliot-Curie, 31059 Toulouse Cedex 9, France

Odile Beyne-Rauzy 7

Hematology, Department of Biomedicine and Prevention, Tor Vergata University. Rome, Italy

Sergio Amadori 7

Department of Emergency and Organ Transplantation, Hematology Section, University of Bari. Bari, Italy

Giorgina Specchia 7

UO Ematologia, AOU “Policlinico-V.Emanuele”. Catania, Italy Giuseppe Palumbo 6

(6)

5 Leukemia Department. The University of Texas MD Anderson

Cancer Center. Texas, Houston, USA

Khanh Nguyen 6

Department of Haematology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China

Huiyong Zhang 5

School of Humanities and Management, Guangdong Medical College. Dongguan, China

Chonghua Wan 5

Hematology Unit, “S. Eugenio Hospital” , Rome, Italy Pasquale Niscola 5

Department of Haematology, S. Giovanni-Addolorata Hospital. Rome, Italy

Luciana Annino 4

Department of Internal Medicine I, University of Freiburg Medical Centre. Freiburg, Germany

Michael Lübbert 4

Department of Oncology-Hematology, Hospital Center

“Pugliese-Ciaccio”. Catanzaro, Italy Luciano Levato 3

Department of Internal Medicine, University of Pavia-IRCCS Policlinico San Matteo Foundation. Pavia, Italy

Carlo Balduini 3

Complex Operative Hematology and Transplantation Unit, Lecce Local Health Service, Lecce, Italy

Nicola Di Renzo 2

Department of Public Health, College of Public Health, National Taiwan University, Roosevelt Road. Taipei, Taiwan, Republic of China

Weichu Chie 2

Department of Haematology, Bradford Institute of Health Research. Bradford, UK

Sam Ackroyd 2

Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute. Milan, Italy

Fabio Ciceri 2

Oncology Department, CHC–Clinique Saint-Joseph. Liège, Belgium

Christian Focan 2

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York. New York, USA

Stephen Nimer 2

Department of Haematology, AZMiddelheim. Antwerp, Belgium Robrecht De Bock 1

Department of Haematology, Hospital de Jolimont. La Louviere, Belgium

Christophe Ravoet 1

Istituto Oncologico Romagnolo per la Cura dei Tumori. Meldola, Italy

Maria Benedetta Giannini 1

Haematology Unit, Sapienza University, Polo Pontino. Latina, Italy

Sergio Mecarocci 1

Department of Haematology, University Campus Bio-medico, Roma, Italy

(7)

6 Division of Hematology, Niguarda Ca' Granda Hospital. Milano,

Italy

Enrica Morra 1

Division of Hematology, Università di Torino, Ospedale San Giovanni Battista. Torino, Italy

Giorgia Matta 1

Department of Onco-hematology, S. Maria della Misericordia Hospital. Rovigo, Italy.

References

Related documents

The Office managed its Recovery Act grant programs effectively and efficiently, complied with laws and regulations, used reliable and accurate data to report program goal

Conclusions: In both age groups, IIV4 was well tolerated and caused no safety concerns, induced robust antibody responses to all 4 influenza strains, and met all EMA

The Contra Costa County Employment and Human Services Department has developed a robust leader- ship development program over many years that includes training and

There is a general consensus among the researchers on the environmental impacts of the various socioeconomic variables (such as economic growth, energy consumption, trade

Further second-order effects of federalism include increasing the level of competition in a political system, and limiting the power of government against citizens in ways that

Initiating a study is not necessarily based on the number of workers involved in the response or a lack of literature on health effects of exposure. The triggers may vary depending

The possible formats in which the system can present feedback to the user are an embodied conversational agent that presents the message to the user by spoken

of the liver where the gall bladder has been removed or from the end of the cystic duct because the clips used to close this have come off. This bile causes intense irritation of